Exclusive

Publication

Byline

Mint Explainer: Is India headed for a cancer drug crisis?

New Delhi, June 9 -- India is facing a critical shortage of two key chemotherapy drugs, cisplatin and carboplatin, primarily due to a steep increase in platinum prices. Doctors and hospitals have rai... Read More


Immuneel eyes West Asia, Asia-Pacific expansion for cancer therapy after Rs.100 crore funding

Mumbai, June 8 -- Cell and gene therapy platform Immuneel Therapeutics is betting that a low-cost Indian model for CAR-T cancer treatment can travel beyond its home market. The biotech firm, backed b... Read More


Mint Explainer | Why India is getting fatter: National survey also reveals dichotomy between urban, rural areas

New Delhi, June 3 -- The latest National Family Health Survey (NFHS-6), released last week, revealed a sharp rise in obesity among adult Indians. Public health organizations and experts have flagged e... Read More


Wockhardt's new drug, India's second to get US nod, now eyes commercial success

Mumbai, June 2 -- Wockhardt's $800-million bet on antibiotic research paid off on Saturday with the US drug regulator's approval for Zaynich, only the second homegrown new drug from India to achieve t... Read More


Medtech exporter Poly Medicure bets on high-tech pivot and acquisitions to fend off macro headwinds

New Delhi, May 28 -- While Indian medtech exporters have faced a host of global headwinds over the past year, including the Red Sea crisis, US tariffs, increasing competition from Chinese rivals, and ... Read More


Mint Explainer: Why is India stepping up Ebola screening?

New Delhi, May 24 -- As cases of Ebola, a severe and often fatal viral infection, spread across African countries last week, the World Health Organization (WHO) termed it an international public healt... Read More


Sun Pharma sales rise 12%, sees softer growth in FY27

Mumbai, May 23 -- After posting double-digit revenue growth in FY26, Sun Pharmaceutical Industries-India's biggest pharmaceutical company by revenue and market capitalization-has projected high single... Read More


Sun Pharma guides for slower FY27 growth amid regulatory, macro challenges

Mumbai, May 22 -- After posting double-digit revenue growth in FY26, Sun Pharmaceutical Industries-India's biggest pharmaceutical company by revenue and market capitalization-has projected high single... Read More


Apollo Hospitals bets on expansion, clinical edge to maintain lead

New Delhi, May 20 -- Apollo Hospitals Enterprise Ltd (AHEL), the country's largest listed hospital chain by beds, is betting on its planned capacity expansion as well as its clinical programmes and ex... Read More


Alembic Pharma bets on branded drugs in the US

Mumbai, May 20 -- Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a 'twin engine play' to boost growth in the market as generic pricing pressure co... Read More